- Case report
- Open Access
Mosaicism for r(X) and der(X)del(X)(p11.23)dup(X)(p11.21p11.22) provides insight into the possible mechanism of rearrangement
© Shchelochkov et al; licensee BioMed Central Ltd. 2008
- Received: 05 May 2008
- Accepted: 25 July 2008
- Published: 25 July 2008
We report a patient with a unique and complex cytogenetic abnormality involving mosaicism for a small ring X and deleted Xp derivative chromosome with tandem duplication at the break point. The patient presented with failure to thrive, muscular hypotonia, and minor facial anatomic anomalies, all concerning for Turner syndrome. Brain MRI revealed mild thinning of the corpus callosum, an apparent decrease in ventricular white matter volume, and an asymmetric myelination pattern. Array comparative genome hybridization analysis revealed mosaicism for the X chromosome, deletion of the short arm of an X chromosome, and a duplication of chromosome region Xp11.21-p11.22. G-banded chromosome and FISH analyses revealed three abnormal cell lines: 46,X,der(X)del(X)(p11.23)dup(X)(p11.21p11.22)/46,X,r(X)(q11.1q13.1)/45,X. The small ring X chromosome was estimated to be 5.2 Mb in size and encompassed the centromere and Xq pericentromeric region. X chromosome inactivation (XCI) studies demonstrated a skewed pattern suggesting that the ring X remained active, likely contributing to the observed clinical features of brain dysmyelination. We hypothesize that a prezygotic asymmetric crossing over within a loop formed during meiosis in an X chromosome with a paracentric inversion resulted in an intermediate dicentric chromosome. An uneven breakage of the dicentric chromosome in the early postzygotic period might have resulted in the formation of one cell line with the X chromosome carrying a terminal deletion and pericentromeric duplication of the short arm and the second cell line with the X chromosome carrying a complete deletion of Xp. The cell line carrying the deletion of Xp could have then stabilized through self-circularization and formation of the ring X chromosome.
- Bacterial Artificial Chromosome
- Bacterial Artificial Chromosome Clone
- Turner Syndrome
- Ring Chromosome
- Terminal Deletion
Turner syndrome is diagnosed in 1 of 5,000 live female births. Six to fifteen percent of patients with Turner syndrome are mosaic carriers of a ring X chromosome. [1, 2]. Several studies in the last decade have made significant contributions to our understanding of the clinical phenotype in patients with r(X) [2–7]. It has been demonstrated that most individuals carrying an r(X) chromosome show somatic signs of Turner syndrome, including short stature, peripheral edema, characteristic facial features, low posterior hairline, ovarian dysgenesis, endocrine disorders, and autoimmune conditions. At the same time, patients with r(X) can be at a higher risk for other findings, including mental retardation, learning difficulties, autistic spectrum disorders, and structural brain abnormalities [4, 8, 9]. These additional features can be partially explained by the status of X inactivation, size, origin, and replication timing of the ring, genes affected by copy number variations, and the percent of mosaicism [3, 6, 8, 10]. Dennis et al. (2000) concluded that severe r(X) phenotype can be seen in patients with active, large r(X) chromosomes lacking the XIST locus. Possible submicroscopic duplications in active ring X chromosomes can go undetected by chromosomal analysis and may encompass dosage sensitive genes, leading to functional disomy or even trisomy, and resulting in clinically relevant phenotypes as has been demonstrated in autosomes . Additionally, a ring chromosome comprised of Y-chromosomal material should be distinguished from that containing X-derived material. Early detection of Y-derived ring chromosomes is necessary since individuals with r(Y) and Turner syndrome are at risk to develop gonadoblastoma, immature teratoma, and endodermal sinus carcinoma, conditions preventable by prophylactic gonadectomy . Special attention has been given also to the possible association between r(X) and Kabuki syndrome [5, 13, 14]. McGinniss et al (1997) have hypothesized that overexpression of dosage sensitive genes from an X chromosome lacking XIST is responsible for some cases with Kabuki syndrome-like features.
Several methods have been used to characterize ring X chromosomes including fluorescence in situ hybridization (FISH), cell replication studies, real time PCR of XIST expression, and the AR locus methylation status. Array comparative genomic hybridization (aCGH) is a novel, clinically validated method that can be applied to studying r(X) chromosomes. CGH microarrays have been used for detection of clinically relevant chromosomal abnormalities in a variety of postnatal patient samples [15–19]. Array CGH adds significantly to our ability to characterize the origin and size of a ring chromosome, to detect chromosomal mosaicism, and to identify additional microscopic deletions or duplications [20–23]. By providing important information about the structural features of ring chromosomes, array CGH also gives new insight into our understanding of the mechanisms of ring formation.
We present a patient with clinical features of Turner syndrome and a complex X chromosome rearrangement, which was detected by chromosomal microarray analysis, and further characterized by G-banding chromosome analysis and X chromosome inactivation studies.
Comparison of the clinical findings between patient RX1 and previously reported patients with r(X).
Short stature/failure to thrive
Special education/Developmental delay
High arched palate
Thin upper lip
Recurrent and chronic otitis media
Low posterior hairline
Bicuspid aortic valve
Aortic valve disease
Short metacarpal bones
Ovarian dysgenesis/ovarian failure
Hypomelanosis of Ito
BAC clones RP11-258C19 (red) and RP11-465B24 (green), corresponding to regions 1 and 2 (Figure 2B), respectively, were used to demonstrate the "red-green-red-green-green" signal pattern in interphase cells (Figure 2D), indicating the direct orientation of the duplication. The metaphase images did not provide sufficient resolution to define the orientation of the tandem duplication relative to the telomere (data not shown). The presence of three green signals (probe RP11-465B24) and two red signals (probe RP11-258C19) on one of the X chromosomes was in agreement with the 244 K array data, consistent with the bimodal distribution of log2 ratios in regions 1 and 2 (Figure 2B).
FISH analysis with a XIST-specific probe showed the presence of two signals in cell line 46,X,der(X) (Figure 3A), one XIST signal in cell lines 46,X,r(X) (Figure 3B) and 45,X, indicating that XIST is not present on the r(X) (Figure 3C). X inactivation (XCI) analysis revealed a 100% skewing of the AR gene: two AR alleles prior to digestion with Hpa II (Figure 3D) and only one AR allele after digestion with methylation-sensitive restriction enzyme Hpa II (Figure 3E). This suggested that the only cell line that has an inactive X chromosome is the cell line with the der(X) and it was preferentially inactivated and that the r(X) chromosome was presumably active.
G-banding chromosome analysis of the mother revealed no abnormalities. An additional maternal blood sample to perform FISH using probes specific to Xp11.2 was not available. A paternal sample was not available for analysis.
This report presents the array CGH and cytogenetic findings in a patient with Turner syndrome due to mosaic r(X) and derivative chromosome with a deleted Xp segment and a tandem duplication of bands Xp11.21-p11.22 at the breakpoint. This combination has not been previously reported. The patient's phenotype at the time of her most recent evaluation at age 26 months included small stature, delayed bone maturation, diffuse muscular hypotonia, seizures, and mild developmental delay. Brain MRI revealed mild thinning of the corpus callosum, an apparent decrease in ventricular white matter volume, and an asymmetric myelination pattern. Of note, there were no features of Kabuki syndrome, a condition previously reported in some patients with r(X) [5, 13, 14]. The most plausible explanation for the brain imaging abnormalities is the overexpression of dosage sensitive genes from the ring X chromosome, which lacks XIST and thus presumably remains active. One of the genes present on the ring chromosome, OPHN1, is known to participate in neuron morphogenesis. When overexpressed in vitro, it can interfere with the actin cytoskeleton, playing a crucial role in axon growth and guidance, dendrite elaboration, and synapse formation .
Array CGH studies detected and provided detailed characterization of the copy number abnormality on chromosome X. The duplication of bands Xp11.21p-11.22, that escaped detection by routine chromosome analysis, was readily seen on the BAC-clone targeted chromosomal microarray and the high resolution oligoarray analyses (Figure 1D, Figure 2A and 2B). The array data was confirmed by FISH, which also localized the duplicated region to the derivative chromosome, and not the r(X) (Figure 3B).
The finding of a duplicated region associated with terminal deletions in a ring chromosome has been described previously [20, 21]. Many of the reported cases had an inverted duplication at the breakpoint. Rossi et al (2007) identified two patients with concurrent deletion and inverted contiguous duplication (inv dup del) in the ring chromosomes and proposed that such abnormality could be the result of recombination between homologous segmental duplications located at the rearrangement's breakpoints leading to an intermediate dicentric chromosome followed by asymmetric breakage of the dicentric. According to this model, inv dup del undergoes an additional step of self-circularization for stabilization of r(X).
Our case is different in two ways: (1) the duplication is tandem and (2) the duplication is present in the non-circular chromosome in the presence of a ring chromosome. The formation of tandem duplication at the terminal breakpoint cannot be explained by concurrent deletion and reunion at Xp, since it would have resulted in inverted duplication, suggesting a different mechanism. Wolff et al (1996) concluded that chromosome region Xp11.2 is prone to breakage and reunion events between sister chromatids or homologous X chromosomes, and could be responsible for the majority of i(Xq) monocentrics or dicentrics. The pericentromeric region of Xp is particularly rich in low copy repeats, thought to be responsible for six classes of i(Xq) originating from breakpoints spanning Xp11.21p11.22 .
The reported unique and complex cytogenetic abnormality involving mosaicism for r(X) and deleted Xp derivative chromosome with tandem duplication at the break point provides insight into the possible mechanism of der(X) and r(X) formation. We suggest that XIST-mediated silencing, size of r(X) and i(Xq), gene content and the level of mosaicism all play important roles in determining phenotypic outcomes. The parents of patients with r(X) and derivative chromosomes with terminal duplications should be offered evaluation using array CGH.
Following the initial result of the chromosomal microarray analysis, an informed consent for the whole genome array-based oligonucleotide CGH study was obtained from the mother. The research protocol was approved by the Institutional Review Board (IRB) for Baylor College of Medicine (BCM) and Affiliated Hospitals.
Chromosome and FISH analyses were performed on peripheral blood lymphocytes using standard procedures. Briefly, the BAC clone of interest was grown in TB media with 20 μg/ml chloramphenicol. DNA was extracted from bacterial artificial chromosome (BAC) clones (Eppendorf Plasmid Mini Prep kit, Hamburg, Germany) and directly labeled with SpectrumOrange™ dUTP by nick translation (Vysis, Downer Grove, IL) according to the manufacturers' instructions. Digital FISH images were captured by a Power Macintosh G3 System and MacProbe version 4.4 (Applied Imaging; San Jose, CA).
The patient's DNA was extracted from whole blood using the Puregene DNA extraction kit (Gentra, Minneapolis, MN) according to the manufacturer's instructions and studied by aCGH using the BAC/PAC microarray platform (CMA V6.1) [26, 27] and the 244 K whole genome oligonucleotide microarray (Agilent, Santa Clara, CA). The BAC/PAC microarray includes 1472 BAC and PAC clones, covers ~150 genomic disorders with minimum backbone coverage of every chromosome at the 650-band level of cytogenetic resolution http://www.bcm.edu/geneticlabs/cma/tables.html. The procedures for probe labeling and hybridization of our BAC arrays were reported previously [26, 27]. For the oligonucleotide microarray study, DNA was digested, labeled, and hybridized according to the manufacturer's instructions, with some modifications . The slides were scanned into image files using a GenePix Model 4000B microarray scanner (Molecular Devices, Sunnyvale, CA) or an Agilent G2565 laser scanner. Microarray image files of oligonucleotide microarrays were quantified using Agilent Feature extraction software (v9.0), and text file outputs from the quantification analysis were imported either into the Agilent CGH Analytics software program or converted to BAC-level emulation data by combining oligo data corresponding to regions encompassed by BAC clones ("emulated BAC clone") and then using custom-written analysis software package for copy number analysis, as described previously [16, 27].
X chromosome inactivation (XCI)
X-inactivation studies were performed according to a previously described protocol with some modifications . Briefly, two sets of reactions were set-up for each female, including 100 ng of genomic DNA digested with the methylation-sensitive restriction enzyme Hpa II (NewEngland Biolabs, Ipswich, MA); and another 100 ng DNA incubated with 1× enzyme buffer only. PCR primers flanking the androgen receptor (AR) CAG repeat region were as follows: 5'-ACCAGGTAGCCTGTGGGGCCTCTACGATGGGC-3' (forward) and 5'-CCAGAGCGTGCGCGAAGTGATCCAGAACCCGG-3' (reverse). PCR amplification was performed using 0.5 ng from each DNA sample. PCR products were analyzed using capillary electrophoresis on the 3100 ABI Automated DNA Sequencer with GeneMapper software. Random X chromosome inactivation is expected to produce two signals if each chromosome has a different AR allele and an intact XIST locus. Non-random inactivation of an X chromosome or the absence of an AR allele in a deleted chromosome will result in PCR amplification of only one allele after digestion with Hpa II.
Written informed consent was obtained from the parent for publication of this case report. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
We are thankful to the family for their cooperation with this study. We are indebted Katie S. Plunkett, MS, CGC, Patricia J. Furman, MPH, CGC, and Pilar L. Magoulas, MS, CGC, for their help in the recruitment of the patient.
- Sybert VP: The adult with Turners syndrome: May 18–21; Gothenburg, Sweden. Edited by: Albertsson-Wikland K, Ranke MB. Amsterdam, Lausanne, New York, Oxford, Shannon, Tokyo: Elsevier; 1995.Google Scholar
- Jacobs P, Dalton P, James R, Mosse K, Power M, Robinson D, Skuse D: Turner syndrome: a cytogenetic and molecular study. Ann Hum Genet 1997 , 61(Pt 6):471–483. 10.1017/S0003480097006507View ArticlePubMedGoogle Scholar
- Dennis N, Coppin B, Turner C, Skuse D, Jacobs P: A clinical, cytogenetic and molecular study of 47 females with r(X) chromosomes. Ann Hum Genet 2000 , 64(Pt 4):277–293. 10.1046/j.1469-1809.2000.6440277.xView ArticlePubMedGoogle Scholar
- Kuntsi J, Skuse D, Elgar K, Morris E, Turner C: Ring-X chromosomes: their cognitive and behavioural phenotype. Ann Hum Genet 2000 , 64(Pt 4):295–305. 10.1046/j.1469-1809.2000.6440295.xView ArticlePubMedGoogle Scholar
- Turner C, Dennis NR, Skuse DH, Jacobs PA: Seven ring (X) chromosomes lacking the XIST locus, six with an unexpectedly mild phenotype. Hum Genet 2000 , 106(1):93–100. 10.1007/s004390051015View ArticlePubMedGoogle Scholar
- Leppig KA, Sybert VP, Ross JL, Cunniff C, Trejo T, Raskind WH, Disteche CM: Phenotype and X inactivation in 45,X/46,X,r(X) cases. Am J Med Genet A 2004 , 128(3):276–284. 10.1002/ajmg.a.30002View ArticleGoogle Scholar
- Liehr T, Mrasek K, Hinreiner S, Reich D, Ewers E, Bartels I, Seidel J, Emmanuil N, Petesen M, Polityko A, Dufke A, Iourov I, Trifonov V, Vermeesch J, Weise A: Small supernumerary marker chromosomes (sSMC) in patients with a 45,X/46,X,+mar karyotype - 17 new cases and a review of the literature. Sex Dev 2007, 1(6):353–362. 10.1159/000111767View ArticlePubMedGoogle Scholar
- Van Dyke DL, Anne Wiktor, Catherine G Paliner, Miller DA, Witt M, V Ramesh Babu, Maria J. Worsham, Jacquelyn R. Roberson, Weiss L: Ullrich-Turner syndrome with a small ring X chromosome and presence of mental retardation. American Journal of Medical Genetics 1992, 43(6):996–1005. 10.1002/ajmg.1320430617View ArticlePubMedGoogle Scholar
- El Abd S, Patton MA, Turk J, Hoey H, Howlin P: Social, communicational, and behavioral deficits associated with ring X turner syndrome. Am J Med Genet 1999 , 88(5):510–516. 10.1002/(SICI)1096-8628(19991015)88:5<510::AID-AJMG14>3.0.CO;2-ZView ArticlePubMedGoogle Scholar
- Wolff DJ, Brown CJ, Schwartz S, Duncan AM, Surti U, Willard HF: Small marker X chromosomes lack the X inactivation center: implications for karyotype/phenotype correlations. Am J Hum Genet 1994 , 55(1):87–95.PubMed CentralPubMedGoogle Scholar
- Bonnet C, Zix C, Grégoire MJ, Brochet K, Duc M, Rousselet F, Philippe C, Jonveaux P: Characterization of mosaic supernumerary ring chromosomes by array-CGH: segmental aneusomy for proximal 4q in a child with tall stature and obesity. Am J Med Genet A 2006 , 140(3):233–237.View ArticlePubMedGoogle Scholar
- Mazzanti L, Cicognani A, Baldazzi L, Bergamaschi R, Scarano E, Strocchi S, Nicoletti A, Mencarelli F, Pittalis M, Forabosco A, Cacciari E: Gonadoblastoma in Turner syndrome and Y-chromosome-derived material. Am J Med Genet A 2005 , 135(2):150–154.View ArticlePubMedGoogle Scholar
- McGinniss MJ, Brown DH, Burke LW, Mascarello JT, Jones MC: Ring chromosome X in a child with manifestations of Kabuki syndrome. Am J Med Genet 1997, 70(1):37–42. 10.1002/(SICI)1096-8628(19970502)70:1<37::AID-AJMG8>3.0.CO;2-OView ArticlePubMedGoogle Scholar
- Dennis NR, Collins AL, Crolla JA, Cockwell AE, Fisher AM, Jacobs PA: Three patients with ring (X) chromosomes and a severe phenotype. J Med Genet 1993 , 30(6):482–486.PubMed CentralView ArticlePubMedGoogle Scholar
- Bejjani BA, Saleki R, Ballif BC, Rorem EA, Sundin K, Theisen A, Kashork CD, Shaffer LG: Use of targeted array-based CGH for the clinical diagnosis of chromosomal imbalance: is less more? Am J Med Genet A 2005 , 134(3):259–267.View ArticlePubMedGoogle Scholar
- Cheung SW, Shaw CA, Yu W, Li J, Ou Z, Patel A, Yatsenko SA, Cooper ML, Furman P, Stankiewicz P, Lupski JR, Chinault AC, Beaudet AL: Development and validation of a CGH microarray for clinical cytogenetic diagnosis. Genet Med 2005 , 7(6):422–432.View ArticlePubMedGoogle Scholar
- de Vries BB, Pfundt R, Leisink M, Koolen DA, Vissers LE, Janssen IM, Reijmersdal S, Nillesen WM, Huys EH, Leeuw N, Smeets D, Sistermans EA, Feuth T, van Ravenswaaij-Arts CM, van Kessel AG, Schoenmakers EF, Brunner HG, Veltman JA: Diagnostic genome profiling in mental retardation. Am J Hum Genet 2005 , 77(4):606–616. 10.1086/491719PubMed CentralView ArticlePubMedGoogle Scholar
- Shaffer LG, Kashork CD, Saleki R, Rorem E, Sundin K, Ballif BC, Bejjani BA: Targeted genomic microarray analysis for identification of chromosome abnormalities in 1500 consecutive clinical cases. J Pediatr 2006, 149(1):98–102. 10.1016/j.jpeds.2006.02.006View ArticlePubMedGoogle Scholar
- Roa BB, Pulliam J, Eng CM, Cheung SW: Evolution of prenatal genetics: from point mutation testing to chromosomal microarray analysis. Expert Rev Mol Diagn 2005 , 5(6):883–892. 10.1586/1473722.214.171.1243View ArticlePubMedGoogle Scholar
- Knijnenburg J, van Haeringen A, Hansson KB, Lankester A, Smit MJ, Belfroid RD, Bakker E, Rosenberg C, Tanke HJ, Szuhai K: Ring chromosome formation as a novel escape mechanism in patients with inverted duplication and terminal deletion. Eur J Hum Genet 2007 , 15(5):548–555. 10.1038/sj.ejhg.5201807View ArticlePubMedGoogle Scholar
- Rossi E, Riegel M, Messa J, Gimelli S, Maraschio P, Ciccone R, Stroppi M, Riva P, Perrotta C, Mattina T, Baumer A, Kucinskas V, Castellan C, Schinzel A, Zuffardi O: Duplications in addition to terminal deletions are present in a proportion of ring chromosomes. Clues to the mechanisms of formation. J Med Genet 2008, 43: 147–54.Google Scholar
- Hermsen MA, Tijssen M, Acero IH, Meijer GA, Ylstra B, Toral JF: High resolution microarray CGH and MLPA analysis for improved genotype/phenotype evaluation of two childhood genetic disorder cases: ring chromosome 19 and partial duplication 2q. Eur J Med Genet 2005 , 48(3):310–318. 10.1016/j.ejmg.2005.04.009View ArticlePubMedGoogle Scholar
- Hayashi S, Honda S, Minaguchi M, Makita Y, Okamoto N, Kosaki R, Okuyama T, Imoto I, Mizutani S, Inazawa J: Construction of a high-density and high-resolution human chromosome X array for comparative genomic hybridization analysis. J Hum Genet 2007, 52(5):397–405. 10.1007/s10038-007-0127-4View ArticlePubMedGoogle Scholar
- Fauchereau F, Herbrand U, Chafey P, Eberth A, Koulakoff A, Vinet MC, Ahmadian MR, Chelly J, Billuart P: The RhoGAP activity of OPHN1, a new F-actin-binding protein, is negatively controlled by its amino-terminal domain. Mol Cell Neurosci 2003, 23(4):574–586. 10.1016/S1044-7431(03)00078-2View ArticlePubMedGoogle Scholar
- Wolff DJ, Miller AP, Van Dyke DL, Schwartz S, Willard HF: Molecular definition of breakpoints associated with human Xq isochromosomes: implications for mechanisms of formation. Am J Hum Genet 1996 , 58(1):154–160.PubMed CentralPubMedGoogle Scholar
- Cheung SW, Shaw CA, Yu W, Li J, Ou Z, Patel A, Yatsenko SA, Cooper ML, Furman P, Stankiewicz P, Lupski JR, Chinault AC, Beaudet AL: Development and validation of a CGH microarray for clinical cytogenetic diagnosis. Genet Med 2005, 7(6):422–432.View ArticlePubMedGoogle Scholar
- Lu X, Shaw CA, Patel A, Li J, Cooper ML, Wells WR, Sullivan CM, Sahoo T, Yatsenko SA, Bacino CA, Stankiewicz P, Ou Z, Chinault AC, Beaudet AL, Lupski JR, Cheung SW, Ward PA: Clinical implementation of chromosomal microarray analysis: summary of 2513 postnatal cases. PLoS ONE 2007, 2(3):e327. 10.1371/journal.pone.0000327PubMed CentralView ArticlePubMedGoogle Scholar
- Probst FJ, Roeder ER, Enciso VB, Ou Z, Cooper ML, Eng P, Li J, Gu Y, Stratton RF, Chinault AC, Shaw CA, Sutton VR, Cheung SW, Nelson DL: Chromosomal microarray analysis(CMA) detects a large X chromosome deletion including FMR1, FMR2, and IDS in a female patient with mental retardation. Am J Med Genet A 2007, 143(12):1358–1365.View ArticleGoogle Scholar
- Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW: Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 1992 , 51(6):1229–1239.PubMed CentralPubMedGoogle Scholar
- Lindgren V, Chen CP, Bryke CR, Lichter P, Page DC, Yang-Feng TL: Cytogenetic and molecular characterization of marker chromosomes in patients with mosaic 45,X karyotypes. Hum Genet 1992 , 88(4):393–398. 10.1007/BF00215672View ArticlePubMedGoogle Scholar
- Prandstraller D, Mazzanti L, Picchio FM, Magnani C, Bergamaschi R, Perri A, Tsingos E, Cacciari E: Turner's syndrome: cardiologic profile according to the different chromosomal patterns and long-term clinical follow-Up of 136 nonpreselected patients. Pediatr Cardiol 1999 , 20(2):108–112. 10.1007/s002469900416View ArticlePubMedGoogle Scholar
- Elsheikh M, Wass JAH, Conway GS: Autoimmune thyroid syndrome in women with Turner's syndrome - the association with karyotype. Clin Endocrinol (Oxf) 2001, 55(2):223–226. 10.1046/j.1365-2265.2001.01296.xView ArticleGoogle Scholar
- Kushnick T, Irons TG, Wiley JE, Gettig EA, Rao KW, Bowyer S: 45X/46X,r(X) with syndactyly and severe mental retardation. Am J Med Genet 1987 , 28(3):567–574. 10.1002/ajmg.1320280304View ArticlePubMedGoogle Scholar
- Cantú ES, Jacobs DF, Pai GS: An atypical Turner syndrome patient with ring X chromosome mosaicism. Ann Clin Lab Sci 1995 , 25(1):60–65.PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.